228 related articles for article (PubMed ID: 27495053)
1. The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer.
Yen TWF; Li J; Sparapani RA; Laud PW; Nattinger AB
Medicine (Baltimore); 2016 Aug; 95(31):e4392. PubMed ID: 27495053
[TBL] [Abstract][Full Text] [Related]
2. Surgeon specialization and use of sentinel lymph node biopsy for breast cancer.
Yen TW; Laud PW; Sparapani RA; Nattinger AB
JAMA Surg; 2014 Feb; 149(2):185-92. PubMed ID: 24369337
[TBL] [Abstract][Full Text] [Related]
3. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
[TBL] [Abstract][Full Text] [Related]
4. National adoption of sentinel node biopsy for breast cancer: lessons learned from the Canadian experience.
Quan ML; Hodgson N; Lovrics P; Porter G; Poirier B; Wright FC
Breast J; 2008; 14(5):421-7. PubMed ID: 18657140
[TBL] [Abstract][Full Text] [Related]
5. Implementation of sentinel lymph node biopsy for breast cancer by surgeons in the Department of Defense.
Davis KG; Schriver JP; Waddell B
Am J Surg; 2002 Aug; 184(2):94-6. PubMed ID: 12169350
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and Consequences of Axillary Lymph Node Dissection in the Era of Sentinel Lymph Node Biopsy for Breast Cancer.
Yen TWF; Laud PW; Pezzin LE; McGinley EL; Wozniak E; Sparapani R; Nattinger AB
Med Care; 2018 Jan; 56(1):78-84. PubMed ID: 29087982
[TBL] [Abstract][Full Text] [Related]
7. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
[TBL] [Abstract][Full Text] [Related]
8. Assessment of hospital-level adjusted breast cancer sentinel lymph node positivity rates.
Berger ER; Bilimoria KY; Kinnier CV; Minami CA; Bethke KP; Hansen NM; Merkow RP; Winchester DP; Yang AD
J Surg Oncol; 2019 Jan; 119(1):101-108. PubMed ID: 30481371
[TBL] [Abstract][Full Text] [Related]
9. Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8
Egger ME; Stevenson M; Bhutiani N; Jordan AC; Scoggins CR; Philips P; Martin RC; McMasters KM
J Am Coll Surg; 2019 Apr; 228(4):466-472. PubMed ID: 30660817
[TBL] [Abstract][Full Text] [Related]
10. The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study.
Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF
Eur J Cancer; 2017 Dec; 87():1-9. PubMed ID: 29096155
[TBL] [Abstract][Full Text] [Related]
11. Adjusted Hospital Sentinel Lymph Node Positivity Rates in Melanoma: A Novel Potential Measure of Quality.
Kinnier CV; Paruch JL; Dahlke AR; Wayne JD; Benson AB; Winchester DP; Bilimoria KY
Ann Surg; 2016 Feb; 263(2):392-8. PubMed ID: 26488806
[TBL] [Abstract][Full Text] [Related]
12. Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast Cancer.
Carleton N; Zou J; Fang Y; Koscumb SE; Shah OS; Chen F; Beriwal S; Diego EJ; Brufsky AM; Oesterreich S; Shapiro SD; Ferris R; Emens LA; Tseng G; Marroquin OC; Lee AV; McAuliffe PF
JAMA Netw Open; 2021 Apr; 4(4):e216322. PubMed ID: 33856473
[TBL] [Abstract][Full Text] [Related]
13. A contemporary, population-based study of lymphedema risk factors in older women with breast cancer.
Yen TW; Fan X; Sparapani R; Laud PW; Walker AP; Nattinger AB
Ann Surg Oncol; 2009 Apr; 16(4):979-88. PubMed ID: 19194754
[TBL] [Abstract][Full Text] [Related]
14. Association of hospital-level factors with utilization of sentinel lymph node biopsy in patients with early-stage vulvar cancer.
Bercow AS; Rauh-Hain JA; Melamed A; Mazina V; Growdon WB; Del Carmen MG; Goodman A; Bouberhan S; Randall T; Sisodia R; Bregar A; Eisenhauer EL; Minami C; Molina G
Gynecol Oncol; 2023 Feb; 169():47-54. PubMed ID: 36508758
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
van Roozendaal LM; Goorts B; Klinkert M; Keymeulen KBMI; De Vries B; Strobbe LJA; Wauters CAP; van Riet YE; Degreef E; Rutgers EJT; Wesseling J; Smidt ML
Breast Cancer Res Treat; 2016 Apr; 156(3):517-525. PubMed ID: 27083179
[TBL] [Abstract][Full Text] [Related]
16. Surgeon-associated variation in breast cancer staging with sentinel node biopsy.
Larson KE; Valente SA; Tu C; Dalton J; Grobmyer SR
Surgery; 2018 Oct; 164(4):680-686. PubMed ID: 30093273
[TBL] [Abstract][Full Text] [Related]
17. Assessing patterns of practice of sentinel lymph node biopsy for breast cancer in Latin America.
Acuna SA; Angarita FA; Escallon J
World J Surg; 2014 May; 38(5):1077-83. PubMed ID: 24305934
[TBL] [Abstract][Full Text] [Related]
18. Predictive Value of Clinicopathological Characteristics for Sentinel Lymph Node Metastasis in Early Breast Cancer.
Ding J; Jiang L; Wu W
Med Sci Monit; 2017 Aug; 23():4102-4108. PubMed ID: 28839123
[TBL] [Abstract][Full Text] [Related]
19. Differential receipt of sentinel lymph node biopsy within practice-based research networks.
Meyer AM; Reeder-Hayes KE; Liu H; Wheeler SB; Penn D; Weiner BJ; Carpenter WR
Med Care; 2013 Sep; 51(9):812-8. PubMed ID: 23942221
[TBL] [Abstract][Full Text] [Related]
20. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
Chin-Lenn L; Mack LA; Temple W; Cherniak W; Quinn RR; Ravani P; Lewin AM; Quan ML
Ann Surg Oncol; 2014 Jan; 21(1):66-73. PubMed ID: 24046105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]